fucoidan
sulfat
polysaccharid
brown
alga
known
immunomodulatori
activ
effect
respons
airway
epitheli
cell
tolllik
receptor
stimul
character
object
evalu
effect
marinesourc
fucoidan
solut
mf
express
andor
product
cytokin
prostaglandin
human
primari
bronchial
epitheli
cell
model
airway
epithelium
cell
incub
mf
presenc
absenc
poli
c
agonist
mimic
viral
rna
cytokin
express
product
assess
use
rtqpcr
elisa
express
product
prostaglandin
also
measur
rel
control
exposur
mf
associ
lower
poli
c
induc
mrna
express
variou
cytokin
chemokin
lower
product
mf
inhibit
product
cytokin
chemokin
prostaglandin
alter
product
clinic
relev
concentr
mf
inhibit
product
inflammatori
mediat
human
primari
bronchial
epitheli
cell
suggest
local
appli
mf
might
help
reduc
airway
inflamm
viral
infect
acut
viral
respiratori
tract
infect
also
known
common
cold
preval
diseas
human
frequent
associ
acut
exacerb
asthma
common
cold
caus
respiratori
virus
rhinoviru
influenza
viru
parainfluenza
viru
coronaviru
respiratori
syncyti
viru
epitheli
cell
constitut
upper
lower
airway
frontlin
defens
inhal
microbi
pathogen
effici
physic
barrier
form
cell
complement
mucociliari
escal
also
contribut
significantli
defens
airway
potenti
harm
inhal
physic
chemic
biolog
agent
infect
airway
epithelium
human
rhinoviru
influenza
viru
trigger
innat
adapt
immun
respons
crucial
effici
antivir
control
airway
epitheli
cell
also
import
role
local
regul
inflammatori
respons
virus
releas
varieti
pleiotrop
cytokin
chemokin
cytokin
exert
number
action
airway
wherea
chemokin
contribut
recruit
activ
select
inflammatori
cell
popul
includ
neutrophil
eosinophil
dendrit
cell
lymphocyt
natur
killer
cell
airway
epitheli
cell
sens
potenti
danger
inhal
materi
latter
interact
pattern
recognit
receptor
tolllik
receptor
tlr
tolllik
receptor
recogn
doublestrand
rna
dsrna
thu
especi
relev
airway
epitheli
cell
respons
rhinoviru
influenza
viru
receptor
express
endosom
compart
dendrit
cell
macrophag
also
detect
surfac
cytoplasm
airway
epitheli
cell
probabl
contribut
regul
cell
innat
respons
seawe
product
use
tradit
chines
herbal
medicin
least
last
year
fucoidan
constitut
main
class
polysaccharid
found
brown
alga
contain
high
level
lfucos
sulfat
ester
group
exert
varieti
antivir
antiinflammatori
immunomodulatori
effect
particular
fucoidan
known
ligand
class
scaveng
receptor
sra
also
belong
pattern
recognit
receptor
famili
known
sra
cell
surfac
receptor
dsrna
may
also
involv
antivir
immun
respons
best
knowledg
fucoidan
effect
releas
inflammatori
mediat
induc
activ
previous
character
object
present
studi
assess
effect
marinesourc
fucoidan
solut
mf
ascophyllum
nodosum
mrna
express
protein
product
cytokin
chemokin
prostaglandin
e
pge
human
primari
bronchial
epitheli
cell
follow
activ
poli
c
synthet
analog
dsrna
antibiot
penicillin
streptomycin
gentamycin
vancomycin
amphotericin
ceftazidim
dmso
lglutamin
heatinactiv
fetal
calf
serum
bovin
pancrea
proteas
hepe
purchas
sigmaaldrich
stquentin
fallavi
franc
roswel
park
memori
institut
rpmi
medium
dulbecco
modifi
eagl
medium
dmem
highglucos
dmem
bovin
serum
albumin
bought
eurobio
biotechnolog
le
uli
franc
highmolecularweight
poli
c
obtain
invivogen
toulous
franc
bronchial
epitheli
cell
growth
medium
begm
supplement
growth
factor
antibiot
purchas
lonza
walkersvil
md
usa
trypsin
edta
obtain
thermo
fisher
scientif
villebon
sur
yvett
franc
cultur
flask
epitheli
cell
cultur
trasadingen
swiss
biocoat
collagenco
cultur
flask
purchas
sigmaaldrich
stquentin
fallavi
franc
cell
cultur
plastic
cml
nemour
franc
untreat
sea
water
drawn
atlant
ocean
coast
brittani
franc
yslab
quimper
franc
prepar
follow
sand
carbon
filter
uv
treatment
steril
filtrat
pore
size
lower
solut
tonic
seawat
salin
reduc
dilut
purifi
water
fucoidanrich
ascophyllum
nodosum
extract
purchas
algu
mer
ouessant
franc
ascophyllum
nodosum
seawe
grown
zone
cover
unesco
world
network
biospher
reserv
achiev
good
ecolog
statu
accord
european
union
water
framework
direct
seawe
thallu
use
fucoidan
extract
main
extract
step
polyphenol
trap
aqueou
extract
solidliquid
separ
microparticl
remov
filtrat
algin
precipit
remov
filtrat
deminer
depolymer
atom
extract
total
sugar
content
weight
accord
duboi
method
use
fucos
sugar
standard
total
sulfat
level
determin
liquid
chromatographi
describ
intern
standard
iso
remain
compon
uron
acid
ash
lfucopyranos
structur
backbon
fucoidan
extract
ascophyllum
nodosum
previous
describ
featur
mean
molecular
weight
gmol
determin
high
perform
size
exclus
chromatographi
coupl
refract
index
detector
prepar
mf
ascophyllum
nodosum
extract
dissolv
final
concentr
mv
dilut
sea
water
concentr
chosen
basi
previou
work
use
resect
lung
tissu
vitro
experi
approv
local
institut
review
board
de
protect
de
personn
iledefr
viii
boulognebillancourt
franc
refer
patient
gave
inform
consent
surgic
procedur
lung
tissu
sampl
obtain
patient
male
femal
smoker
former
smoker
nonsmok
mean
standard
error
sd
age
year
packyear
copd
undergo
surgic
resect
lung
carcinoma
receiv
prior
chemotherapi
none
subject
treat
immunosuppress
corticosteroid
surgeri
proxim
segment
bronchi
collect
site
distant
tumor
place
highglucos
dmem
supplement
lglutamin
fetal
calf
serum
hepe
antibiot
antifung
drug
penicillin
streptomycin
gentamycin
vancomycin
amphotericin
ceftazidim
store
bacteri
decontamin
least
day
bronchial
mucu
remov
bronchu
cut
lengthwis
addit
proteas
overnight
follow
day
lumin
surfac
bronchu
sampl
gentli
scratch
order
detach
epitheli
cell
cultur
medium
centrifug
cell
suspens
cell
pellet
resuspend
ml
supplement
highglucos
dmem
place
cultur
flask
h
co
atmospher
supernat
recov
place
biocoat
collagenco
flask
follow
day
everi
day
cultur
medium
replac
ml
antibioticfre
highglucos
dmem
ml
begm
refer
hereaft
begmdmem
cell
reach
confluenc
usual
day
cultur
detach
plate
trypsin
centrifug
resuspend
begmdmem
plate
ml
per
well
h
prior
exposur
pharmacolog
agent
plate
wash
ml
fresh
begmdmem
ad
per
well
cell
incub
either
sodium
chlorid
control
mf
h
solut
remov
cell
incub
ml
cultur
medium
absenc
presenc
highmolecularweight
poli
c
cell
h
cell
cultur
supernat
collect
store
later
analysi
product
select
chemokin
cytokin
assess
measur
concentr
bronchial
epitheli
cell
supernat
use
commerci
avail
elisa
duoset
develop
system
r
system
europ
lill
franc
limit
detect
pgml
level
pge
determin
use
commerci
avail
elisa
cayman
chemic
europ
tallinn
estonia
cell
viabil
assess
measur
ldh
releas
nonradioact
cytotox
assay
promega
madison
usa
total
rna
prepar
use
reagent
life
technolog
saint
aubin
franc
rna
extract
accord
manufactur
instruct
rna
intact
determin
run
aliquot
sampl
experion
autom
electrophoresi
station
biorad
marneslacoquett
franc
rna
concentr
determin
use
biowav
dna
spectrophotomet
biochrom
cambridg
uk
next
total
rna
reversetranscrib
use
iii
firststrand
supermix
kit
life
technolog
specif
array
base
predesign
reagent
life
technolog
use
assay
cytokin
chemokin
transcript
custom
array
fast
plate
appli
biosystem
foster
citi
usa
revers
transcriptasequantit
pcr
perform
use
gene
express
master
mix
life
technolog
ng
cdna
steponeplu
thermocycl
life
technolog
thermal
cycl
condit
follow
initi
denatur
min
follow
cycl
min
housekeep
gene
hypoxanthin
phosphoribosyltransferas
use
signal
normal
statist
analysi
perform
use
prism
softwar
version
graphpad
softwar
la
jolla
ca
usa
oneway
analysi
varianc
repeat
measur
friedman
test
appropri
follow
posttest
pair
student
ttest
wilcoxon
test
appropri
use
compar
treatment
mf
poli
c
control
onehour
incub
mf
h
cultur
medium
alon
associ
elev
ldh
releas
epitheli
cell
rel
control
thu
demonstr
absenc
cytotox
tabl
exposur
poli
c
associ
elev
express
rel
control
experi
gene
code
cytokin
fig
howev
preincub
epitheli
cell
mf
inhibit
poli
c
induc
elev
express
gene
elev
gene
express
complet
block
mf
incub
mf
gener
alter
baselin
product
cytokin
chemokin
nonstimul
cell
tabl
howev
incub
mf
associ
slight
rel
increas
baselin
product
tabl
poli
c
induc
mark
elev
product
measur
cytokineschemokin
except
vari
extent
tabl
preincub
mf
significantli
inhibit
product
tabl
fig
similarli
preincub
mf
inhibit
poli
c
induc
product
chemokin
other
tabl
fig
exposur
mf
alter
low
baselin
level
pge
product
nonstimul
bronchial
epitheli
cell
data
shown
markedli
inhibit
poli
c
induc
product
pge
fig
observ
line
mf
inhibit
poli
c
associ
elev
express
fig
object
present
studi
explor
effect
seawat
solut
depolymer
fucoidan
ascophyllum
nodosum
human
bronchial
epitheli
cell
hour
exposur
mf
enough
inhibit
poli
c
induc
elev
cytokinechemokin
mrna
express
protein
product
mrna
express
product
pge
human
bronchial
epitheli
cell
h
fucoidan
abund
sulfat
polysaccharid
found
brown
alga
last
decad
fucoidan
purifi
differ
speci
brown
alga
extens
studi
broad
spectrum
desir
biolog
activ
includ
anticoagul
antithrombot
antitumor
antiinflammatori
immunomodulatori
effect
recent
vitro
studi
raw
macrophag
fucoidan
purifi
marin
brown
alga
chnoospora
minima
found
inhibit
lipopolysaccharid
lp
induc
product
nitrou
oxid
pge
via
downregul
induc
nitric
oxid
synthas
ino
express
ii
product
furthermor
sulfat
polysaccharid
extract
brown
seawe
sargassum
hemiphyllum
sargassum
horneri
shown
reduc
proinflammatori
cytokin
product
product
express
ino
lpsstimul
raw
macrophag
macrophag
mechan
underli
fucoidan
antiinflammatori
action
yet
elucid
howev
report
fucoidan
regul
signal
pathway
involv
map
kinas
sinc
mf
influenc
epitheli
cell
viabil
inhibitori
effect
due
nonspecif
toxic
present
studi
first
demonstr
fucoidan
extract
ascophyllum
nodosum
dissolv
dilut
seawat
also
antiinflammatori
effect
human
primari
bronchial
epitheli
cell
particular
mf
inhibit
effect
bronchial
epitheli
cell
synthet
virallik
dsrna
poli
c
suggest
fucoidan
might
dampen
epithelium
inflammatori
respons
viral
infect
addit
inhibit
product
variou
proinflammatori
cytokin
chemokin
inhibit
pge
may
benefici
effect
reduc
mucu
secret
studi
need
determin
whether
exposur
mf
lower
mucu
secret
nasal
epithelium
addit
fucoidan
algal
polysaccharid
reportedli
exert
antivir
activ
variou
mechan
action
inhibit
viru
bind
intern
suppress
dna
replic
andor
protein
synthesi
scaveng
receptor
describ
function
coreceptor
process
endocytosi
might
lie
interfac
sever
underli
mechan
inde
activ
srafucoidan
complex
depend
endocytosi
endosom
intern
cellsurfac
critic
epitheli
cell
respons
poli
c
present
studi
srafucoidan
complex
may
endocytos
along
onehour
exposur
mf
thu
would
longer
present
cell
surfac
poli
c
ad
thu
block
respons
tlr
agonist
howev
studi
requir
determin
exact
mechan
action
airway
epithelium
continu
expos
multitud
noxiou
challeng
inhal
air
import
role
regul
local
inflammatori
respons
viral
infect
upper
lower
airway
earlier
research
shown
human
bronchial
epitheli
cell
cultur
accur
recapitul
function
characterist
human
nasal
epitheli
cell
could
therefor
serv
surrog
latter
inde
two
cell
type
morpholog
histolog
function
similar
respect
ciliari
activ
react
variou
agonist
antagonist
similar
manner
experi
nasal
bronchial
epitheli
cell
harvest
children
cystic
fibrosi
wide
varieti
cftr
mutat
cell
type
stimul
inhibit
level
cftr
similar
studi
human
bronchial
nasal
epitheli
cell
level
cytokin
chemokin
releas
vitro
similar
nonstimul
cell
cell
stimul
even
rhinoviru
infect
inde
nasal
epitheli
cell
show
much
cytokin
respons
bronchial
epitheli
cell
expos
rhinoviru
airliquid
interfac
cultur
submerg
cultur
condit
observ
particularli
relev
present
studi
taken
whole
find
strongli
suggest
nasal
bronchial
airway
epitheli
cell
use
interchang
thu
ii
observ
mf
antiinflammatori
effect
bronchial
epitheli
cell
legitim
transpos
nasal
epitheli
cell
common
cold
caus
respiratori
virus
whose
number
divers
antigen
variabl
limit
develop
effect
vaccin
although
infect
usual
selflimit
affect
peopl
age
group
still
caus
signific
morbid
present
standard
therapi
common
cold
gener
care
treatment
symptom
overthecount
antihistamin
commonli
use
reliev
symptom
shortterm
benefici
effect
appear
effect
children
overthecount
nasal
decongest
also
use
although
effect
safeti
children
clinic
relev
small
symptomat
effect
adult
yet
demonstr
furthermor
avail
evid
support
use
intranas
corticosteroid
symptomat
relief
common
cold
recent
shown
iotacarrageenan
sulfat
polysaccharid
found
speci
red
seawe
exert
potent
activ
respiratori
virus
directli
bind
infecti
particl
howev
carrageenan
enter
host
cell
expect
exert
pharmacolog
immun
activ
although
iotacarrageenan
found
effect
nasal
spray
three
clinic
trial
fail
achiev
statist
signific
outcom
primari
secondari
endpoint
recent
studi
nasal
irrig
salin
often
employ
adjunct
treatment
acut
upper
respiratori
tract
infect
particularli
children
might
reliev
symptom
extent
mf
assess
readytous
topic
appli
solut
combin
nasal
salin
irrig
topic
deliveri
fucoidan
conclus
studi
result
suggest
fucoidan
could
use
prevent
treat
viralinduc
airway
inflamm
mf
may
therefor
combin
symptomat
benefit
local
irrig
antiinflammatori
activ
treatment
common
cold
